Infectious Complications, Healthcare Resource Use, and Medical Costs Associated with Delays in Percutaneous Nephrolithotomy Among Patients with Stone Disease and Ureteral Stent Placement
Journal of Endourology · 2023
DOI: 10.1089/end.2022.0489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endourology, 2023. Verfasst von Naeem Bhojani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Nephrolithotomy, Percutaneous, Nephrostomy, Percutaneous, Ureter, Kidney Calculi. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The relationship between ureteral stent duration before percutaneous nephrolithotomy (PCNL) and infectious complications, admissions, imaging, and medical costs was evaluated. Materials and Methods: Patients who underwent PCNL within 6 months of ureteral stent placement were identified from commercial claims, categorized by time to treatment (0–30, 31–60, and >60 days), and followed 1-month post-PCNL. The effect of delayed treatment on inpatient admissions, infectious complications (pyelonephritis/sepsis), and imaging utilization was evaluated with logistic regression. A generalized linear model evaluated the effect of delayed treatment on medical costs.
Results
Among 564 patients with PCNL and meeting the inclusion criteria (mean age 50; 55% female; 45% from South), mean (standard deviation) time to surgery was 48.8 (41.8) days. Less than half (44.3%; n = 250) underwent PCNL within 30 days of ureteral stent placement, 27.0% ( n = 152) between 31 and 60 days, and 28.7% ( n = 162) >60 days. Time to PCNL was significantly associated with inpatient admissions (>60 vs ≤30 days odds ratio [OR] 1.97, 95% confidence interval [CI] 1.29–3.01, p = 0.0016), infectious complications (>60 vs ≤30 days OR 2.43, 95% CI 1.55–3.81, p = 0.0001), imaging utilization (31–60 vs ≤30 days OR 1.56, 95% CI 1.02–2.38, p = 0.0383; >60 vs ≤30 days OR 2.01, 95% CI 1.31–3.06, p = 0.0012), and medical costs (31–60 vs ≤30 days OR 1.27, 95% CI 1.08–1.49, p = 0.0048; >60 vs ≤30 days OR 1.46, 95% CI 1.24–1.71, p < 0.0001).
Conclusions
Compared with PCNL within 30 days, patients undergoing PCNL >30 days after ureteral stent placement had increased likelihood of infectious complications, resource use, and medical costs. These results may inform health care resource utilization and PCNL prioritization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
- Division of Urology, Boston Scientific, Marlborough, Massachusetts, USA.
- Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Naeem Bhojani
Zitieren
APA
Bhojani, N., Paranjpe, R., Cutone, B., & Eisner, B. H. (2023). Infectious Complications, Healthcare Resource Use, and Medical Costs Associated with Delays in Percutaneous Nephrolithotomy Among Patients with Stone Disease and Ureteral Stent Placement. Journal of Endourology. https://doi.org/10.1089/end.2022.0489
Vancouver
Bhojani N, Paranjpe R, Cutone B, Eisner BH. Infectious Complications, Healthcare Resource Use, and Medical Costs Associated with Delays in Percutaneous Nephrolithotomy Among Patients with Stone Disease and Ureteral Stent Placement. Journal of Endourology. 2023. doi:10.1089/end.2022.0489
BibTeX
@article{Bhojani2023,
author = {Bhojani, Naeem and Paranjpe, Rutugandha and Cutone, Benjamin and Eisner, Brian H},
title = {Infectious Complications, Healthcare Resource Use, and Medical Costs Associated with Delays in Percutaneous Nephrolithotomy Among Patients with Stone Disease and Ureteral Stent Placement},
journal = {Journal of Endourology},
year = {2023},
doi = {10.1089/end.2022.0489}
}
EUVIMED